Conditional Expression of Hepatocyte Nuclear Factor-1B, the Maturity-Onset

Total Page:16

File Type:pdf, Size:1020Kb

Conditional Expression of Hepatocyte Nuclear Factor-1B, the Maturity-Onset 171 Conditional expression of hepatocyte nuclear factor-1b, the maturity-onset diabetes of the young-5 gene product, influences the viability and functional competence of pancreatic b-cells Hannah J Welters, Sabine Senkel1, Ludger Klein-Hitpass1, Silke Erdmann1, Heike Thomas1, Lorna W Harries, Ewan R Pearson, Coralie Bingham, Andrew T Hattersley, Gerhart U Ryffel1 and Noel G Morgan Institute of Biomedical and Clinical Science, Peninsula Medical School, Universities of Exeter and Plymouth, Research Way, Plymouth, Devon PL6 8BU,UK 1Institut fu¨r Zellbiologie, Universita¨tsklinikum Essen, D-45122 Essen, Germany (Requests for offprints should be addressed to N G Morgan; Email: [email protected]) Abstract Mutations in the gene encoding hepatocyte nuclear factor apoptosis. Induction of WT HNF1b also inhibited the insulin (HNF)1b result in maturity-onset diabetes of the young- secretory response to nutrient stimuli, membrane depolaris- (MODY)5, by impairing insulin secretory responses and, ation or activation of protein kinases A and C and this possibly, by reducing b-cell mass. The functional role of correlated with a significant decrease in pancrease-duodenum HNF1b in normal b-cells is poorly understood; therefore, in homeobox-1 protein levels. The attenuation of insulin the present study, wild-type (WT) HNF1b, or one of two secretion was, however, dissociated from the inhibition of naturally occurring MODY5 mutations (an activating proliferation and loss of viability, since expression of the mutation, P328L329del, or a dominant-negative form, P328L329del mutant led to a reduced rate of cell A263insGG) were conditionally expressed in the pancreatic proliferation, but failed to induce apoptosis or to alter insulin b-cell line, insulin-1 (INS-1), and the functional conse- secretion. Taken together, the present results suggest that quences examined. Surprisingly, overexpression of the mature rodent b-cells are sensitive to increased expression of dominant-negative mutant did not modify any of the WT HNF1b and they imply that the levels of this protein are functional properties of the cells studied (including insulin tightly regulated to maintain secretory competence and cell secretion, cell growth and viability). By contrast, expression of viability. WT HNF1b was associated with a time- and dose-dependent inhibition of INS-1 cell proliferation and a marked increase in Journal of Endocrinology (2006) 190, 171–181 Introduction the functional competence of the pancreatic b-cell and, as a consequence, mutations that lead to altered transcriptional or Maturity-onset diabetes of the young (MODY) is an early enzymatic activity are sufficient to cause b-cell defects and onset form of monogenic type II diabetes, which typically hence diabetes. As yet, the MODY5 gene, HNF1b, has not presents before 25 years (Fajans et al. 2001, Owen & been ascribed a clear role in pancreatic b-cells. Hattersley 2001) and is inherited in an autosomal dominant HNF1a and 1b are nuclear transcription factors of the manner. MODY patients have a primary defect at the level of homeodomain family. Their genes are located on different the b-cell caused by mutations in specific genes. Most of these chromosomes in man, but the two may have arisen by an genes encode transcription factors, including hepatocyte original gene duplication event during evolution (Bach et al. nuclear factor-(HNF)4a (MODY1) (Yamagata et al. 1996a), 1991). The proteins share a high degree of sequence HNF1a (MODY3) (Yamagata et al. 1996b), pancreas- homology, but are most divergent within the C-terminal duodenum homeobox-1 (PDX-1; MODY4) (Stoffers et al. transactivation domain. HNF1a and -1b bind to the same 1997), HNF1b (MODY5) (Horikawa et al. 1997, Nishigori DNA consensus sequence and they can interact with this et al. 1998, Lindner et al. 1999, Bingham et al. 2000, Bingham region either as homodimers or as an HNF1a/1b hetero- & Hattersley 2004) and neuroD1/Beta2 (MODY6) (Malecki dimer (Mendel et al. 1991, Bach & Yaniv 1993, Cereghini et al. 1999). The exception is MODY2, which is caused by 1996). mutations in the glucokinase gene (Froguel et al. 1993). In Despite the apparent similarities between HNF1a and -1b, most cases, the MODY genes are known to be important for it is likely that they undertake distinct functional roles within Journal of Endocrinology (2006) 190, 171–181 DOI: 10.1677/joe.1.06768 0022–0795/06/0190–171 q 2006 Society for Endocrinology Printed in Great Britain Online version via http://www.endocrinology-journals.org Downloaded from Bioscientifica.com at 09/25/2021 02:56:21PM via free access 172 H J WELTERS and others $ Function of HNF1b in pancreatic b-cells the b-cell, as evidenced by the different phenotypes seen revealed that alterations in glucose homeostasis can occur in in MODY3 and MODY5 patients. Patients with mutations RIP-Cre mice that are unrelated to changes in the gene of in HNF1b have an impaired insulin secretory response interest (Lee et al. 2006). to glucose and sulphonylureas (Nishigori et al. 1998, Bingham In order to investigate the function of HNF1b in mature et al. 2000, Ryffel 2001, Pearson et al. 2004) and they exhibit a b-cells without the potential complications arising from RIP- progressive loss in basal insulin secretion, suggesting a decline Cre-recombinase-mediated knockout, we have used a clonal in b-cell mass. In contrast, MODY3 patients retain a robust b-cell line (INS-1) to conditionally express either wild-type insulin secretory response to sulphonylureas despite the (WT) HNF1b or one of two naturally occurring mutants attenuation of glucose-induced insulin secretion (Pearson identified in patients with MODY5 (A263insGG and et al. 2003, 2004). Thus, it seems likely that HNF1a and -1b P328L329del). The mutation P328L329del (abbreviated to exert differential effects in the b-cell and that the latter may P328del) leads to the synthesis of a protein having a severely regulate both secretory competence and cell viability. truncated transactivation domain, but that retains the DNA Previous studies have established that HNF1a is expressed binding and dimerisation domains (Fig. 1) (Bingham et al. in mature b-cells and that it promotes the transcription of a 2000). From studies in HeLa cells, P328del has been reported range of genes in these cells. These include several genes that to possess increased transcriptional activity compared with are critical for the maintenance of the b-cell phenotype, such WT HNF1b (Wild et al. 2000), although examination of the as Glut-2, PDX-1, L-type pyruvate kinase and possibly profile of genes that are up-regulated in response to the insulin (Wang et al. 1998, Ben-Shushan et al. 2001, Shih et al. expression of this mutant in INS-1 cells suggests that it may be 2001). HNF1a may also be required for the proliferation of less active than the WT (Thomas et al. 2004). The A263insGG b-cells as it has been demonstrated to regulate genes involved (A263ins) mutant has no transactivation domain and a in control of the cell cycle, such as cyclin E, p27 and insulin- truncated DNA-binding domain that is non-functional like growth factor-I (Wobser et al. 2002, Yang et al. 2002). (Senkel et al. 2005). However, A263ins can still form dimers In contrast, little is known about the role of HNF1b in with WT HNF1b and this has been suggested to result in b-cells. Homozygous HNF1b knockout mice are non-viable, dominant-negative activity against the native form in a variety with death occurring soon after implantation of the embryo of cell types, including the pancreatic b-cell line MIN6 (7$5 embryo days in mice) (Barbacci et al. 1999, Coffinier (Nishigori et al. 1998, Tomura et al. 1999, Bai et al. 2002). et al. 1999), making the function of HNF1b difficult to study using whole animal knockout approaches. In experiments where HNF1b has been selectively deleted in mature mouse b-cells (using Cre-recombinase expressed under the control Materials and Methods of the insulin promoter (RIP-Cre)), there was evidence of Cell culture impaired glucose tolerance and reduced insulin secretion. These are correlated with alterations in the functional activity Pancreatic b-cell lines (INS-1) that conditionally express of other b-cell transcription factors such that PDX-1 and human WT HNF1b or one of two mutant forms, designated HNF1a were increased and HNF4a decreased (Wang et al. P328del or A263ins, were used in these experiments. These 2004). These results suggest that the expression of HNF1b cell lines were recently described in detail by Thomas et al. may be required to maintain the differentiation state and (2004) but, briefly, cDNAs encoding WTor the mutant forms functional activity of mature b-cells (Coffinier et al. 1999, of HNF1b were cloned downstream of the Tet operator in Wang et al. 2004). However, the experiments must be the plasmid pcDNA5/FRT/TO. This plasmid was integrated interpreted with caution, since it has subsequently been by site-directed Flp recombination into the insulinoma cell Dimerisation DNA binding Transactivation WT HNF1β 1 32 88 176 231 313 557 A263insGG 264 P328L329del 356 Figure 1 Structure of the HNF1b protein. Schematic diagram of HNF1b protein structure showing wild-type and the two truncated proteins encoded by MODY5 mutations. The native protein contains a dimerisation domain, a DNA-binding domain and a transactivation domain. The numbers refer to the amino acid positions in WT HNF1b. Journal of Endocrinology (2006) 190, 171–181 www.endocrinology-journals.org Downloaded from Bioscientifica.com at 09/25/2021 02:56:21PM via free access Function of HNF1b in pancreatic b-cells $ H J WELTERS and others 173 clone INS1-Flp-In-T-Rex. Stable cell lines containing 8 mM probe in a total reaction volume of 20 ml on the TaqMan the HNF1b gene were obtained by hygromycin selection.
Recommended publications
  • Sorbonne Université/China Scholarship Council Program 2021
    Sorbonne Université/China Scholarship Council program 2021 Thesis proposal Title of the research project: Hnf1b regulation during kidney development and regeneration Joint supervision: no Joint PhD (cotutelle): no Thesis supervisor: … Muriel Umbhauer. Email address of the thesis supervisor: [email protected] Institution: …… Sorbonne Université …. Doctoral school (N°+name): ED …. …… ED 515 Complexité du Vivant Research laboratory: UMR7622 CNRS Laboratory of developmental biology Name of the laboratory director: … Sylvie Schneider-Maunoury Email address of the laboratory director: [email protected] Subject description (2 pages max): 1) Study context The POU homeodomain transcription factor hepatocyte nuclear factor 1β (Hnf1b) plays an essential role in vertebrate kidney development. Heterozygous mutations in human HNF1B cause the complex multisystem syndrome known as Renal Cysts And Diabetes (RCAD). The most prominent clinical features of this autosomal dominant disorder are non-diabetic renal disease resulting from abnormal renal development and diabetes mellitus (reviewed by Clissold RL et al., 2015). During early mouse kidney development, Hnf1b has been shown to be required for ureteric bud branching and initiation of nephrogenesis (Lokmane et al., 2010). Hnf1b conditional inactivation in murine nephron progenitors has revealed an additional role in segment fate Xenopus is a well established and attractive model to study kidney development (Krneta-Stankic V. et al, 2017). Renal function at larval stages relies on two pronephroi located on both sides of the body, each consisting on one giant nephron displaying the same structural and functional organisation than the mammalian nephron. Moreover, pronephric and metanephric differentiation and morphogenesis share most of the signalling cascades and gene regulatory networks.
    [Show full text]
  • Overlap of Vitamin a and Vitamin D Target Genes with CAKUT- Related Processes [Version 1; Peer Review: 1 Approved with Reservations]
    F1000Research 2021, 10:395 Last updated: 21 JUL 2021 BRIEF REPORT Overlap of vitamin A and vitamin D target genes with CAKUT- related processes [version 1; peer review: 1 approved with reservations] Ozan Ozisik1, Friederike Ehrhart 2,3, Chris T Evelo 2, Alberto Mantovani4, Anaı̈s Baudot 1,5 1Aix Marseille University, Inserm, MMG, Marseille, 13385, France 2Department of Bioinformatics - BiGCaT, Maastricht University, Maastricht, 6200 MD, The Netherlands 3Department of Bioinformatics, NUTRIM/MHeNs, Maastricht University, Maastricht, 6200 MD, The Netherlands 4Istituto Superiore di Sanità, Rome, 00161, Italy 5Barcelona Supercomputing Center (BSC), Barcelona, 08034, Spain v1 First published: 18 May 2021, 10:395 Open Peer Review https://doi.org/10.12688/f1000research.51018.1 Latest published: 18 May 2021, 10:395 https://doi.org/10.12688/f1000research.51018.1 Reviewer Status Invited Reviewers Abstract Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) are a 1 group of abnormalities affecting the kidneys and their outflow tracts, which include the ureters, the bladder, and the urethra. CAKUT version 1 patients display a large clinical variability as well as a complex 18 May 2021 report aetiology, as only 5% to 20% of the cases have a monogenic origin. It is thereby suspected that interactions of both genetic and 1. Elena Menegola, Università degli Studi di environmental factors contribute to the disease. Vitamins are among the environmental factors that are considered for CAKUT aetiology. In Milano, Milan, Italy this study, we collected vitamin A and vitamin D target genes and Any reports and responses or comments on the computed their overlap with CAKUT-related gene sets.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Supplemental Materials ZNF281 Enhances Cardiac Reprogramming
    Supplemental Materials ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression Huanyu Zhou, Maria Gabriela Morales, Hisayuki Hashimoto, Matthew E. Dickson, Kunhua Song, Wenduo Ye, Min S. Kim, Hanspeter Niederstrasser, Zhaoning Wang, Beibei Chen, Bruce A. Posner, Rhonda Bassel-Duby and Eric N. Olson Supplemental Table 1; related to Figure 1. Supplemental Table 2; related to Figure 1. Supplemental Table 3; related to the “quantitative mRNA measurement” in Materials and Methods section. Supplemental Table 4; related to the “ChIP-seq, gene ontology and pathway analysis” and “RNA-seq” and gene ontology analysis” in Materials and Methods section. Supplemental Figure S1; related to Figure 1. Supplemental Figure S2; related to Figure 2. Supplemental Figure S3; related to Figure 3. Supplemental Figure S4; related to Figure 4. Supplemental Figure S5; related to Figure 6. Supplemental Table S1. Genes included in human retroviral ORF cDNA library. Gene Gene Gene Gene Gene Gene Gene Gene Symbol Symbol Symbol Symbol Symbol Symbol Symbol Symbol AATF BMP8A CEBPE CTNNB1 ESR2 GDF3 HOXA5 IL17D ADIPOQ BRPF1 CEBPG CUX1 ESRRA GDF6 HOXA6 IL17F ADNP BRPF3 CERS1 CX3CL1 ETS1 GIN1 HOXA7 IL18 AEBP1 BUD31 CERS2 CXCL10 ETS2 GLIS3 HOXB1 IL19 AFF4 C17ORF77 CERS4 CXCL11 ETV3 GMEB1 HOXB13 IL1A AHR C1QTNF4 CFL2 CXCL12 ETV7 GPBP1 HOXB5 IL1B AIMP1 C21ORF66 CHIA CXCL13 FAM3B GPER HOXB6 IL1F3 ALS2CR8 CBFA2T2 CIR1 CXCL14 FAM3D GPI HOXB7 IL1F5 ALX1 CBFA2T3 CITED1 CXCL16 FASLG GREM1 HOXB9 IL1F6 ARGFX CBFB CITED2 CXCL3 FBLN1 GREM2 HOXC4 IL1F7
    [Show full text]
  • UNIVERSITY of CALIFORNIA, IRVINE Combinatorial Regulation By
    UNIVERSITY OF CALIFORNIA, IRVINE Combinatorial regulation by maternal transcription factors during activation of the endoderm gene regulatory network DISSERTATION submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Biological Sciences by Kitt D. Paraiso Dissertation Committee: Professor Ken W.Y. Cho, Chair Associate Professor Olivier Cinquin Professor Thomas Schilling 2018 Chapter 4 © 2017 Elsevier Ltd. © 2018 Kitt D. Paraiso DEDICATION To the incredibly intelligent and talented people, who in one way or another, helped complete this thesis. ii TABLE OF CONTENTS Page LIST OF FIGURES vii LIST OF TABLES ix LIST OF ABBREVIATIONS X ACKNOWLEDGEMENTS xi CURRICULUM VITAE xii ABSTRACT OF THE DISSERTATION xiv CHAPTER 1: Maternal transcription factors during early endoderm formation in 1 Xenopus Transcription factors co-regulate in a cell type-specific manner 2 Otx1 is expressed in a variety of cell lineages 4 Maternal otx1 in the endodermal conteXt 5 Establishment of enhancers by maternal transcription factors 9 Uncovering the endodermal gene regulatory network 12 Zygotic genome activation and temporal control of gene eXpression 14 The role of maternal transcription factors in early development 18 References 19 CHAPTER 2: Assembly of maternal transcription factors initiates the emergence 26 of tissue-specific zygotic cis-regulatory regions Introduction 28 Identification of maternal vegetally-localized transcription factors 31 Vegt and OtX1 combinatorially regulate the endodermal 33 transcriptome iii
    [Show full text]
  • Acquired Evolution of Mitochondrial Metabolism Regulated by HNF1B in Ovarian Clear Cell Carcinoma
    cancers Review Acquired Evolution of Mitochondrial Metabolism Regulated by HNF1B in Ovarian Clear Cell Carcinoma Ken Yamaguchi 1,*, Sachiko Kitamura 1, Yoko Furutake 1 , Ryusuke Murakami 1,2 , Koji Yamanoi 1, Mana Taki 1, Masayo Ukita 1, Junzo Hamanishi 1 and Masaki Mandai 1 1 Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan; [email protected] (S.K.); [email protected] (Y.F.); [email protected] (R.M.); [email protected] (K.Y.); [email protected] (M.T.); [email protected] (M.U.); [email protected] (J.H.); [email protected] (M.M.) 2 Department of Gynecology, Shiga General Hospital, Moriyama, Shiga 524-8524, Japan * Correspondence: [email protected]; Tel.: +81-75-751-3269 Simple Summary: Ovarian clear cell carcinoma (CCC) exhibits unique characteristics, including slow growth, glycogen accumulation in the cytoplasm, and poor prognosis for stress resistance. Several molecular targeting agents have failed to treat ovarian CCC. Recent reports have identified metabolic alterations through HNF1B, which is highly expressed in ovarian CCC. The Warburg effect, GSH synthesis, and mitochondrial regulation occur in CCC. The metabolic behaviors of ovarian CCC resemble the evolution of life to survive in stressful environments. Understanding the fundamental biology of ovarian CCC might help in the development of novel therapeutic strategies. Citation: Yamaguchi, K.; Kitamura, Abstract: Clear cell carcinoma (CCC) of the ovary exhibits a unique morphology and clinically S.; Furutake, Y.; Murakami, R.; malignant behavior.
    [Show full text]
  • NICU Gene List Generator.Xlsx
    Neonatal Crisis Sequencing Panel Gene List Genes: A2ML1 - B3GLCT A2ML1 ADAMTS9 ALG1 ARHGEF15 AAAS ADAMTSL2 ALG11 ARHGEF9 AARS1 ADAR ALG12 ARID1A AARS2 ADARB1 ALG13 ARID1B ABAT ADCY6 ALG14 ARID2 ABCA12 ADD3 ALG2 ARL13B ABCA3 ADGRG1 ALG3 ARL6 ABCA4 ADGRV1 ALG6 ARMC9 ABCB11 ADK ALG8 ARPC1B ABCB4 ADNP ALG9 ARSA ABCC6 ADPRS ALK ARSL ABCC8 ADSL ALMS1 ARX ABCC9 AEBP1 ALOX12B ASAH1 ABCD1 AFF3 ALOXE3 ASCC1 ABCD3 AFF4 ALPK3 ASH1L ABCD4 AFG3L2 ALPL ASL ABHD5 AGA ALS2 ASNS ACAD8 AGK ALX3 ASPA ACAD9 AGL ALX4 ASPM ACADM AGPS AMELX ASS1 ACADS AGRN AMER1 ASXL1 ACADSB AGT AMH ASXL3 ACADVL AGTPBP1 AMHR2 ATAD1 ACAN AGTR1 AMN ATL1 ACAT1 AGXT AMPD2 ATM ACE AHCY AMT ATP1A1 ACO2 AHDC1 ANK1 ATP1A2 ACOX1 AHI1 ANK2 ATP1A3 ACP5 AIFM1 ANKH ATP2A1 ACSF3 AIMP1 ANKLE2 ATP5F1A ACTA1 AIMP2 ANKRD11 ATP5F1D ACTA2 AIRE ANKRD26 ATP5F1E ACTB AKAP9 ANTXR2 ATP6V0A2 ACTC1 AKR1D1 AP1S2 ATP6V1B1 ACTG1 AKT2 AP2S1 ATP7A ACTG2 AKT3 AP3B1 ATP8A2 ACTL6B ALAS2 AP3B2 ATP8B1 ACTN1 ALB AP4B1 ATPAF2 ACTN2 ALDH18A1 AP4M1 ATR ACTN4 ALDH1A3 AP4S1 ATRX ACVR1 ALDH3A2 APC AUH ACVRL1 ALDH4A1 APTX AVPR2 ACY1 ALDH5A1 AR B3GALNT2 ADA ALDH6A1 ARFGEF2 B3GALT6 ADAMTS13 ALDH7A1 ARG1 B3GAT3 ADAMTS2 ALDOB ARHGAP31 B3GLCT Updated: 03/15/2021; v.3.6 1 Neonatal Crisis Sequencing Panel Gene List Genes: B4GALT1 - COL11A2 B4GALT1 C1QBP CD3G CHKB B4GALT7 C3 CD40LG CHMP1A B4GAT1 CA2 CD59 CHRNA1 B9D1 CA5A CD70 CHRNB1 B9D2 CACNA1A CD96 CHRND BAAT CACNA1C CDAN1 CHRNE BBIP1 CACNA1D CDC42 CHRNG BBS1 CACNA1E CDH1 CHST14 BBS10 CACNA1F CDH2 CHST3 BBS12 CACNA1G CDK10 CHUK BBS2 CACNA2D2 CDK13 CILK1 BBS4 CACNB2 CDK5RAP2
    [Show full text]
  • 1714 Gene Comprehensive Cancer Panel Enriched for Clinically Actionable Genes with Additional Biologically Relevant Genes 400-500X Average Coverage on Tumor
    xO GENE PANEL 1714 gene comprehensive cancer panel enriched for clinically actionable genes with additional biologically relevant genes 400-500x average coverage on tumor Genes A-C Genes D-F Genes G-I Genes J-L AATK ATAD2B BTG1 CDH7 CREM DACH1 EPHA1 FES G6PC3 HGF IL18RAP JADE1 LMO1 ABCA1 ATF1 BTG2 CDK1 CRHR1 DACH2 EPHA2 FEV G6PD HIF1A IL1R1 JAK1 LMO2 ABCB1 ATM BTG3 CDK10 CRK DAXX EPHA3 FGF1 GAB1 HIF1AN IL1R2 JAK2 LMO7 ABCB11 ATR BTK CDK11A CRKL DBH EPHA4 FGF10 GAB2 HIST1H1E IL1RAP JAK3 LMTK2 ABCB4 ATRX BTRC CDK11B CRLF2 DCC EPHA5 FGF11 GABPA HIST1H3B IL20RA JARID2 LMTK3 ABCC1 AURKA BUB1 CDK12 CRTC1 DCUN1D1 EPHA6 FGF12 GALNT12 HIST1H4E IL20RB JAZF1 LPHN2 ABCC2 AURKB BUB1B CDK13 CRTC2 DCUN1D2 EPHA7 FGF13 GATA1 HLA-A IL21R JMJD1C LPHN3 ABCG1 AURKC BUB3 CDK14 CRTC3 DDB2 EPHA8 FGF14 GATA2 HLA-B IL22RA1 JMJD4 LPP ABCG2 AXIN1 C11orf30 CDK15 CSF1 DDIT3 EPHB1 FGF16 GATA3 HLF IL22RA2 JMJD6 LRP1B ABI1 AXIN2 CACNA1C CDK16 CSF1R DDR1 EPHB2 FGF17 GATA5 HLTF IL23R JMJD7 LRP5 ABL1 AXL CACNA1S CDK17 CSF2RA DDR2 EPHB3 FGF18 GATA6 HMGA1 IL2RA JMJD8 LRP6 ABL2 B2M CACNB2 CDK18 CSF2RB DDX3X EPHB4 FGF19 GDNF HMGA2 IL2RB JUN LRRK2 ACE BABAM1 CADM2 CDK19 CSF3R DDX5 EPHB6 FGF2 GFI1 HMGCR IL2RG JUNB LSM1 ACSL6 BACH1 CALR CDK2 CSK DDX6 EPOR FGF20 GFI1B HNF1A IL3 JUND LTK ACTA2 BACH2 CAMTA1 CDK20 CSNK1D DEK ERBB2 FGF21 GFRA4 HNF1B IL3RA JUP LYL1 ACTC1 BAG4 CAPRIN2 CDK3 CSNK1E DHFR ERBB3 FGF22 GGCX HNRNPA3 IL4R KAT2A LYN ACVR1 BAI3 CARD10 CDK4 CTCF DHH ERBB4 FGF23 GHR HOXA10 IL5RA KAT2B LZTR1 ACVR1B BAP1 CARD11 CDK5 CTCFL DIAPH1 ERCC1 FGF3 GID4 HOXA11 IL6R KAT5 ACVR2A
    [Show full text]
  • The Expression of Genes Contributing to Pancreatic Adenocarcinoma Progression Is Influenced by the Respective Environment – Sagini Et Al
    The expression of genes contributing to pancreatic adenocarcinoma progression is influenced by the respective environment – Sagini et al Supplementary Figure 1: Target genes regulated by TGM2. Figure represents 24 genes regulated by TGM2, which were obtained from Ingenuity Pathway Analysis. As indicated, 9 genes (marked red) are down-regulated by TGM2. On the contrary, 15 genes (marked red) are up-regulated by TGM2. Supplementary Table 1: Functional annotations of genes from Suit2-007 cells growing in pancreatic environment Categoriesa Diseases or p-Valuec Predicted Activation Number of genesf Functions activationd Z-scoree Annotationb Cell movement Cell movement 1,56E-11 increased 2,199 LAMB3, CEACAM6, CCL20, AGR2, MUC1, CXCL1, LAMA3, LCN2, COL17A1, CXCL8, AIF1, MMP7, CEMIP, JUP, SOD2, S100A4, PDGFA, NDRG1, SGK1, IGFBP3, DDR1, IL1A, CDKN1A, NREP, SEMA3E SERPINA3, SDC4, ALPP, CX3CL1, NFKBIA, ANXA3, CDH1, CDCP1, CRYAB, TUBB2B, FOXQ1, SLPI, F3, GRINA, ITGA2, ARPIN/C15orf38- AP3S2, SPTLC1, IL10, TSC22D3, LAMC2, TCAF1, CDH3, MX1, LEP, ZC3H12A, PMP22, IL32, FAM83H, EFNA1, PATJ, CEBPB, SERPINA5, PTK6, EPHB6, JUND, TNFSF14, ERBB3, TNFRSF25, FCAR, CXCL16, HLA-A, CEACAM1, FAT1, AHR, CSF2RA, CLDN7, MAPK13, FERMT1, TCAF2, MST1R, CD99, PTP4A2, PHLDA1, DEFB1, RHOB, TNFSF15, CD44, CSF2, SERPINB5, TGM2, SRC, ITGA6, TNC, HNRNPA2B1, RHOD, SKI, KISS1, TACSTD2, GNAI2, CXCL2, NFKB2, TAGLN2, TNF, CD74, PTPRK, STAT3, ARHGAP21, VEGFA, MYH9, SAA1, F11R, PDCD4, IQGAP1, DCN, MAPK8IP3, STC1, ADAM15, LTBP2, HOOK1, CST3, EPHA1, TIMP2, LPAR2, CORO1A, CLDN3, MYO1C,
    [Show full text]
  • UC San Diego UC San Diego Electronic Theses and Dissertations
    UC San Diego UC San Diego Electronic Theses and Dissertations Title Insights from reconstructing cellular networks in transcription, stress, and cancer Permalink https://escholarship.org/uc/item/6s97497m Authors Ke, Eugene Yunghung Ke, Eugene Yunghung Publication Date 2012 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, SAN DIEGO Insights from Reconstructing Cellular Networks in Transcription, Stress, and Cancer A dissertation submitted in the partial satisfaction of the requirements for the degree Doctor of Philosophy in Bioinformatics and Systems Biology by Eugene Yunghung Ke Committee in charge: Professor Shankar Subramaniam, Chair Professor Inder Verma, Co-Chair Professor Web Cavenee Professor Alexander Hoffmann Professor Bing Ren 2012 The Dissertation of Eugene Yunghung Ke is approved, and it is acceptable in quality and form for the publication on microfilm and electronically ________________________________________________________________ ________________________________________________________________ ________________________________________________________________ ________________________________________________________________ Co-Chair ________________________________________________________________ Chair University of California, San Diego 2012 iii DEDICATION To my parents, Victor and Tai-Lee Ke iv EPIGRAPH [T]here are known knowns; there are things we know we know. We also know there are known unknowns; that is to say we know there
    [Show full text]
  • Hepatocyte Nuclear Factor 1B–Associated Kidney Disease: More Than Renal Cysts and Diabetes
    BRIEF REVIEW www.jasn.org Hepatocyte Nuclear Factor 1b–Associated Kidney Disease: More than Renal Cysts and Diabetes Jacobien C. Verhave, Anneke P. Bech, Jack F.M. Wetzels, and Tom Nijenhuis Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands ABSTRACT Hepatocyte nuclear factor 1b (HNF1b)–associated disease is a recently recognized of this disease for the clinician. We illus- clinical entity with a variable multisystem phenotype. Early reports described an trate the heterogenic presentation of association between HNF1B mutations and maturity-onset diabetes of the young. HNF1b-associated disease on the basis These patients often presented with renal cysts and renal function decline that pre- of five selected patients, and we then ceded the diabetes, hence it was initially referred to as renal cysts and diabetes provide a concise review of the associated syndrome. However, it is now evident that many more symptoms occur, and diabe- signs and symptoms and their molecular tes and renal cysts are not always present. The multisystem phenotype is probably pathogenesis. attributable to functional promiscuity of the HNF1b transcription factor, involved in the development of the kidney, urogenital tract, pancreas, liver, brain, and para- HETEROGENIC PRESENTATION thyroid gland. Nephrologists might diagnose HNF1b-associated kidney disease in OF THE MULTISYSTEM patients referred with a suspected diagnosis of autosomal dominant polycystic kid- PHENOTYPE OF HNF1b- ney disease, medullary cystic kidney disease, diabetic nephropathy, or CKD of un- ASSOCIATED DISEASE known cause. Associated renal or extrarenal symptoms should alert the nephrologist to HNF1b-associated kidney disease. A considerable proportion of fi these patients display hypomagnesemia, which sometimes mimics Gitelman syn- The rst patient, a woman aged 39 years, drome.
    [Show full text]
  • The Mutation Spectrum of Maturity Onset Diabetes of the Young (MODY)-Associated Genes Among Western Siberia Patients
    Journal of Personalized Medicine Article The Mutation Spectrum of Maturity Onset Diabetes of the Young (MODY)-Associated Genes among Western Siberia Patients Dinara E. Ivanoshchuk 1,2,* , Elena V. Shakhtshneider 1,2 , Oksana D. Rymar 2, Alla K. Ovsyannikova 2, Svetlana V. Mikhailova 1, Veniamin S. Fishman 1, Emil S. Valeev 1, Pavel S. Orlov 1,2 and Mikhail I. Voevoda 1 1 Federal Research Center Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (SB RAS), Prospekt Lavrentyeva 10, 630090 Novosibirsk, Russia; [email protected] (E.V.S.); [email protected] (S.V.M.); [email protected] (V.S.F.); [email protected] (E.S.V.); [email protected] (P.S.O.); [email protected] (M.I.V.) 2 Institute of Internal and Preventive Medicine—Branch of Institute of Cytology and Genetics, SB RAS, Bogatkova Str. 175/1, 630004 Novosibirsk, Russia; [email protected] (O.D.R.); [email protected] (A.K.O.) * Correspondence: [email protected] or [email protected]; Tel.: +7-(383)-363-4963; Fax: +7-(383)-333-1278 Abstract: Maturity onset diabetes of the young (MODY) is a congenital form of diabetes characterized by onset at a young age and a primary defect in pancreatic-β-cell function. Currently, 14 subtypes of MODY are known, and each is associated with mutations in a specific gene: HNF4A, GCK, HNF1A, PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS, BLK, KCNJ11, ABCC8, and APPL1. The most common subtypes of MODY are associated with mutations in the genes GCK, HNF1A, HNF4A, and HNF1B.
    [Show full text]